Grand River Aseptic Manufacturing, Inc. (GRAM), a leading parenteral contract development and manufacturing organization, has implemented its fully-automated serialization and aggregation processes for commercial injectable drug products. The implementation comes four years ahead of the November 2023 deadline outlined in the Drug Supply Chain Security Act (DSCSA).   The DSCSA was signed into law in November of 2013 to reduce the spread of counterfeit drugs. The legislation outlines steps to buil...